The global dry eye disease market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to accelerate the growth of the market during the forecast period include the rising prevalence of aging population and increasing incidences of ocular surface diseases. The other factor that is anticipated to fuel the market growth includes the increasing usage of the computer or digital screens may cause less blinking, which may contribute to symptoms of dry eye disease. The majority of the population uses computers and even more of them constantly deal with smartphones, digital devices, and tablet computers. A significant percentage of the global population (middle age to older age) suffers from dry eye disease. The disease is particularly more common among women than in men. According to the World Ageing 2019 report, there were about 703 million population aged 65 years or over in the world in 2019. This number is projected to double to 1.5 billion in 2050. As the number of the elderly population is projected to increase, eye-related disorders, such as dry eye will increase, which ultimately drives the market growth in the near future.

In June 2021, Kala Pharmaceuticals. launched Eysuvis, short-term treatment of dry eye disease. Eysuvis uses Kala’s proprietary Ampplify mucus-penetrating particle drug delivery technology for enhanced penetration of loteprednol etabonate into target ocular surface tissue to treat signs and symptoms of dry eye disease. In October 2019, Sun Pharmaceutical Industries Ltd. launched CEQUA for the treatment of Dry Eye Disease in the US. CEQUA 0.09% for topical ophthalmic use is the first and only approved cyclosporine treatment delivered with NCELL technology. However, the high cost of specialty dry eye products with complex reimbursement scenarios and availability of alternative therapies is likely to limit the market growth during the forecast period.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Alcon Vision LLC, Bausch Health Companies Inc., and AbbVie Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Dry Eye Disease Market Report by Segment

By Product

• Artificial Tears

• Anti-inflammatory Drugs

• Punctal Plugs

• Secretagogues

• Others

By Distribution Channel

• Hospital Pharmacies

• Independent Pharmacies and Drug Stores

• Online Pharmacies

Global Dry Eye Disease Market by Region